22 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
quality management;
business ethics, including anti-corruption and healthcare compliance matters; and
employee recruitment, development and retention
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance … and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.
(rr) Liquidity
424B3
cj8ch2
8 Aug 22
Prospectus supplement
5:47pm
S-4
9xg10hl1 tqamct7
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
8-K
EX-1.1
4u141pebvnzd4nu
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
8-K
EX-2.1
d7lrj3
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-1.2
nhj 6zdo7jetxti
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
1x7tnhz
8 Apr 19
Entry into a Material Definitive Agreement
12:00am